KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Rigel Pharmaceuticals (RIGL) over the last 14 years, with Q3 2025 value amounting to 0.91%.

  • Rigel Pharmaceuticals' Return on Capital Employed rose 7900.0% to 0.91% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.91%, marking a year-over-year increase of 7900.0%. This contributed to the annual value of 0.31% for FY2024, which is 6000.0% up from last year.
  • Rigel Pharmaceuticals' Return on Capital Employed amounted to 0.91% in Q3 2025, which was up 7900.0% from 1.0% recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Return on Capital Employed ranged from a high of 1.0% in Q2 2025 and a low of 1.06% during Q3 2022
  • In the last 5 years, Rigel Pharmaceuticals' Return on Capital Employed had a median value of 0.13% in 2024 and averaged 0.18%.
  • In the last 5 years, Rigel Pharmaceuticals' Return on Capital Employed tumbled by -9900bps in 2022 and then surged by 11300bps in 2025.
  • Rigel Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.11% in 2021, then plummeted by -744bps to 0.93% in 2022, then skyrocketed by 65bps to 0.33% in 2023, then surged by 184bps to 0.27% in 2024, then surged by 234bps to 0.91% in 2025.
  • Its last three reported values are 0.91% in Q3 2025, 1.0% for Q2 2025, and 0.43% during Q1 2025.